(Q3)Apr 30, 2021 | (Q2)Jan 31, 2021 | (Q1)Oct 31, 2020 | (FY)Jul 31, 2020 | (Q4)Jul 31, 2020 | (Q3)Apr 30, 2020 | (Q2)Jan 31, 2020 | (Q1)Oct 31, 2019 | (FY)Jul 31, 2019 | (Q4)Jul 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 331.77%1.23M | -2,521.41%-1.08M | -300.23%-1.1M | 89.20%-1.14M | 8.23%-1.11M | -2.22%-531.62K | 99.34%-41.1K | 121.57%548.62K | 43.07%-10.54M | 81.88%-1.21M |
Net income from continuing operations | 83.65%-901.47K | 346.24%1.93M | -44.44%-1.23M | 5.87%-24.98M | -58.33%-17.83M | -65.81%-5.51M | 88.17%-783.55K | 83.96%-854.88K | -9.90%-26.54M | -103.00%-11.26M |
Operating gains losses | --0 | --0 | -92.65%56.23K | 5,476.36%8.41M | --3.61M | --3.76M | --273.89K | --765.31K | 111.45%150.76K | ---- |
Depreciation and amortization | 24.91%9.09K | -42.77%6.18K | -25.31%6.18K | -6.48%35.94K | 0.69%9.59K | -23.62%7.28K | 30.48%10.8K | -25.48%8.28K | 834.78%38.43K | 842.14%9.53K |
Asset impairment expenditure | ---- | ---- | ---- | 19.90%10.71M | ---- | ---- | ---- | ---- | 3,142.23%8.93M | ---- |
Unrealized gains and losses of investment securities | 187.40%983.88K | ---1.83M | 1,292.71%278.54K | -477.49%-2.21M | -507.85%-1.1M | ---1.13M | --0 | -93.64%20K | 237.70%584.44K | 163.57%269.83K |
Remuneration paid in stock | ---- | --0 | --0 | -67.96%557.77K | --105.85K | -71.21%173.89K | --12.04K | -76.60%265.99K | -53.89%1.74M | --0 |
Deferred tax | ---- | ---- | ---- | 652.50%4.57M | ---- | ---- | ---- | ---- | ---827.61K | ---- |
Other non cashItems | -89.43%2K | 116.54%30K | 101.35%1.13K | -181.71%-376.21K | -135.49%-130.36K | 112.00%18.94K | -869.12%-181.39K | -136.68%-83.41K | -88.27%460.44K | 20.26%367.3K |
Change In working capital | -47.06%1.14M | -292.74%-1.21M | -148.16%-205.81K | -56.47%2.14M | -193.25%-1.07M | -8.43%2.15M | 92.66%627.11K | -61.01%427.34K | 901.81%4.91M | 306,614.75%1.14M |
-Change in receivables | 90.32%-11.33K | 63.81%-11.78K | -144.38%-11.71K | 208.17%281.45K | 200.94%404.76K | -132.60%-117.13K | 59.52%-32.56K | 119.12%26.38K | 42.00%-260.19K | -30.27%-400.99K |
-Change in prepaid assets | -26.07%7.08K | -162.41%-55.99K | 501.45%76.52K | -124.17%-230.72K | -148.09%-310.94K | -95.08%9.57K | -39.94%89.71K | 47.11%-19.06K | 394.78%954.63K | -25.70%646.6K |
-Change in payables and accrued expense | -49.39%1.14M | -300.17%-1.14M | -164.43%-270.62K | -50.50%2.09M | -229.21%-1.16M | 25.82%2.26M | 122.15%569.96K | -66.93%420.02K | 2,543.43%4.22M | 259.49%897.69K |
Cash from discontinued investing activities | 0 | -61.30%-1.95M | -2.6M | |||||||
Operating cash flow | 331.77%1.23M | -2,521.41%-1.08M | -300.23%-1.1M | 90.89%-1.14M | 70.74%-1.11M | -607.77%-531.62K | 99.29%-41.1K | 118.30%548.62K | 36.66%-12.5M | 51.86%-3.81M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -1,112.15%-50K | -87.48%-185K | -25.52%118.79K | 1,168.52%1.62M | 113.80%1.55M | 104.98%4.94K | -1,332.21%-98.68K | 120.72%159.49K | 97.42%-151.17K | 128.57%724.74K |
Net PPE purchase and sale | -2,320.14%-50K | 7.50%-185K | ---100K | 93.72%-77.07K | 134.47%125K | 97.92%-2.07K | -2,802.76%-200K | --0 | 56.98%-1.23M | 70.52%-362.6K |
Net business purchase and sale | --0 | --0 | 37.18%218.79K | -25.71%807.81K | -49.42%550K | --7.01K | --91.32K | --159.49K | 677.59%1.09M | --1.09M |
Net other investing changes | ---- | ---- | ---- | 8,140.91%884.5K | --874.5K | --0 | ---- | ---- | 89.63%-11K | --0 |
Cash from discontinued investing activities | 0 | -316.20%-181.88K | 0 | |||||||
Investing cash flow | -1,112.15%-50K | -87.48%-185K | -25.52%118.79K | 584.99%1.62M | 113.80%1.55M | 104.21%4.94K | -981.93%-98.68K | 116.76%159.49K | 94.35%-333.05K | 128.08%724.74K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -551.78%-1.14M | 15,013.36%1.17M | 3,727.33%455.3K | -100.16%-10.47K | -630.22%-243.05K | 44,167.42%252.95K | -100.14%-7.82K | -101.84%-12.55K | -78.27%6.37M | -100.22%-33.28K |
Net issuance payments of debt | -606.65%-1.28M | 14,320.97%1.89M | -3,766.96%-272.7K | 95.79%-10.47K | -4.19%-243.05K | 4,099.79%252.95K | -188.77%-13.32K | -52.87%-7.05K | ---248.83K | ---233.28K |
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -76.55%6.81M | --0 |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -94.47%178.09K | --0 |
Net other financing activities | ---- | ---- | 13,336.38%728K | ---- | ---- | ---- | ---- | -101.07%-5.5K | 87.57%-360.77K | 114.56%200K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -563.95%-1.17M | 15,013.36%1.17M | 3,727.33%455.3K | -100.16%-10.47K | -630.22%-243.05K | 44,167.42%252.95K | -100.14%-7.82K | -101.84%-12.55K | -78.27%6.37M | -100.22%-33.28K |
Net cash flow | ||||||||||
Beginning cash position | -99.41%4.18K | -88.28%100.1K | 293.95%624.53K | -97.60%158.53K | -86.79%432.75K | -78.53%706.49K | -74.49%854.08K | -97.60%158.53K | 128.25%6.61M | 42.78%3.28M |
Current changes in cash | 103.14%8.6K | 35.01%-95.92K | -175.40%-524.42K | 107.22%465.99K | 106.15%191.77K | -1,982.26%-273.73K | -156.50%-147.6K | 121.30%695.55K | -273.71%-6.45M | -172.21%-3.12M |
End cash Position | -97.05%12.78K | -99.41%4.18K | -88.28%100.1K | 293.95%624.53K | 293.95%624.53K | -86.79%432.75K | -78.53%706.49K | -74.49%854.08K | -97.60%158.53K | -97.60%158.53K |
Free cash from | 321.51%1.18M | -423.56%-1.26M | -318.46%-1.2M | 91.14%-1.22M | 76.28%-989.68K | -9,792.83%-533.69K | 95.84%-241.1K | 114.61%548.62K | 39.23%-13.72M | 54.37%-4.17M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data